本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Syros Pharmaceuticals, Inc.

0.0250
-0.0001-0.40%
成交量:4.97萬
成交額:1,249.61
市值:67.08萬
市盈率:-0.01
高:0.0273
開:0.0245
低:0.0245
收:0.0251
資料載入中...
2023/03/02

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/02

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/30

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/25

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/09

重要事件披露

8-K - Current report
2022/12/20

SEC問詢函

CORRESP [Cover] - Correspondence
2022/12/16

重要事件披露

8-K/A [Amend] - Current report
2022/12/12

重要事件披露

8-K - Current report
2022/12/01

重要事件披露

8-K/A [Amend] - Current report
2022/11/30

SEC問詢函

CORRESP [Cover] - Correspondence
2022/11/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/06

重要事件披露

8-K - Current report
2022/09/20

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/19

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/16

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/09/16

重要事件披露

8-K - Current report
2022/09/16

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership